Skip to main content
Premium Trial:

Request an Annual Quote

Michael Christman

Michael Christman, president and CEO of the Coriell Institute for Medical Research, has died. He joined Coriell in 2007 and founded the Coriell Personalized Medicine Collaborative, which studies the utility of genetics in medicine. He also co-founded pharmacogenomics company Coriell Life Sciences and served as chairman of its board of directors. Previously, he was a professor and founding chair of the Department of Genetics and Genomics at Boston University School of Medicine. Before that, he was an associate professor at the University of California, San Francisco. Christman held a doctorate in biochemistry from the University of California, Berkeley, and a bachelor's degree in chemistry from the University of North Carolina, Chapel Hill. He was also a postdoctoral fellow at the Massachusetts Institute of Technology.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.